Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2010
10/14/2010US20100260685 Contrast agents
10/14/2010US20100260684 Use of 3-alkanoyloxymethoxycarbonyl nitroxide esters as oximetry probes for measurement of oxygen status in tissues
10/14/2010US20100260682 Compounds and methods of use thereof for assaying lysophospholipase D activity
10/14/2010US20100260681 Adrenocorticotropic hormone analogs and related methods
10/14/2010US20100260680 Novel bone mass increasing agent
10/14/2010US20100260679 Method and apparatus for detecting and regulating vascular endothelial growth factor (vegf) by forming a homeostatic loop employing a half-antibody biosensor
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010US20100260677 Methods and systems for treatment and/or diagnosis
10/14/2010US20100260676 Precision-guided nanoparticle systems for drug delivery
10/14/2010US20100260675 Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010CA2757723A1 Method of predicting a predisposition to qt prolongation based on abcc2 gene sequence or product thereof
10/14/2010CA2757646A1 Method of predicting a predisposition to qt prolongation based on bai3 gene sequence or product thereof
10/13/2010EP2239577A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
10/13/2010EP2237802A2 Method to produce hyperpolarised amino acids and aminosulphonic acids
10/13/2010EP2237801A1 Mr imaging agent or medium compressing hzperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used
10/13/2010EP1781284B1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/13/2010EP1146910B1 Preparations for time-limited marking of biopsy sites
10/13/2010CN1433326B Method for determining viability of myocardial segment
10/12/2010US7811832 Administering an apoptosis inhibitor to a mammal having an eye with retinal detachment
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/12/2010US7811550 Chemical reduction process to form magnetic metal core, sulfiding to form metal sulfide seed crystal, coating a fluorescent semiconductor material on sulfide surface; biosensors with optical and magnetical activities, visual detection of a test strip
10/12/2010CA2245494C Human c-ha-ras proto-oncogene transgenic rat
10/07/2010WO2010114308A1 Heterocycle-amino acid derivatives for targeting cancer tissue and radioactive or non-radioactive labeled compounds thereof
10/07/2010WO2010113157A1 Lipopeptide inhibitors of hiv-1
10/07/2010WO2010048623A9 Medical and imaging nanoclusters
10/07/2010US20100257634 Bioassay for gene silencing constructs
10/07/2010US20100257616 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
10/07/2010US20100256484 Optically matching medium and method for obtaining such a medium
10/07/2010US20100256330 Peptide-based compounds
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100254913 Non-spherical contrast agents for cest mri based on bulk magnetic susceptibility effect
10/07/2010US20100254911 Multimodal nanoparticles for non-invasive bio-imaging
10/07/2010US20100254910 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/07/2010US20100254909 Thermolabile liposome with a controlled release temperature
10/07/2010US20100254908 Process for production of surface-coated inorganic particles
10/07/2010US20100254907 Methods for the treatment of tinnitus induced by cochlear excitotoxicity
10/07/2010US20100254905 Inhibitors of bruton's tyrosine kinase
10/07/2010US20100254904 Novel therapeutic delivery systems
10/07/2010US20100254901 Compositions comprising nucleic acid aptamers
10/07/2010US20100254900 Biocompatible polymers and Methods of use
10/07/2010US20100254897 Seeds and Markers for Use in Imaging
10/07/2010US20100254896 Methods and compositions related to adenoassociated virus-phage particles
10/06/2010EP2236508A1 Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates
10/06/2010EP2235188A2 Transgenic non-human animals expressing human blood clotting factors
10/06/2010EP2234490A2 Substituted 4-{3-ý6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl¨-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists
10/06/2010EP1283060B1 Preparations for diagnosing infection with helicobacter pylori
10/06/2010CN101854956A Imaging medium comprising hyperpolarised 13C-acetate and use thereof
10/06/2010CN101854917A Vesicles comprising a transmembrane transport trigger system
10/06/2010CN101851635A Preparation method for novel fusion protein reversing renal fibrosis and activity detection
10/06/2010CN101851628A Method for cloning and expressing recombinant chicken interferon (IFN)-gamma genes and detecting activity of recombinant chicken IFN-gamma genes
10/06/2010CN101851503A Ir-Gd metal complex fluorescent nanoparticle and preparation method and application thereof
10/06/2010CN101850227A Preparation method for nano particle and nano-particle sol and application of nano particle and nano-particle sol in magnetic resonance imaging contrast medium
10/06/2010CN101850127A White spirit drunkenness degree evaluation model
10/06/2010CA2686326A1 Dental diagnostic system by means of optical coherence tomography
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807623 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
10/05/2010US7807618 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues
10/05/2010US7807468 Methods of marking and testing pharmaceutical products
10/05/2010US7807400 Methods for identifying chemical modulators of Ras superfamily GTPase activity
10/05/2010US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule
10/05/2010US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer
10/05/2010US7807139 Use of outer membrane protein A (OMPA) in treatment/prevention/diagnosis of infections caused by Klebsiella pneumoniae and other gram-negative bacteria
10/05/2010US7807137 Iron complex; paramagnetism; exhibits contrast enhancement in computer tomography; octanuclear iron-pyrazolate cluster
10/05/2010US7807136 Treatment of stomach cancer with steroid compounds and precipitation
10/05/2010US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H
10/05/2010CA2439381C Paramagnetic nanoparticles
10/05/2010CA2361530C Methods and chemical preparations for time-limited marking of biopsy sites
09/2010
09/30/2010WO2010111219A2 Site localization and methods for monitoring treatment of disturbed blood vessels
09/30/2010WO2010110881A1 Improved transceiver apparatus, system, and methodology for superior in-vivo imaging of human anatomy
09/30/2010WO2010071293A9 Target indicator for radiological treatment
09/30/2010WO2010070126A3 Smart contrast agents for mri imaging
09/30/2010US20100251394 Treatment and prevention of ischemic brain injury
09/30/2010US20100251393 Transgenic animals
09/30/2010US20100251392 Methods for assessing the delivery of exogenous agents
09/30/2010US20100249386 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010US20100249373 Screening methods
09/30/2010US20100247627 Foxn1 and pigmentation
09/30/2010US20100247448 Novel lanthanide ligands and complexes, and use thereof as contrast agents
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/30/2010US20100247446 Method and system for analyzing optical signal
09/30/2010US20100247444 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method
09/30/2010US20100247443 Effectiveness evaluating method, effectiveness evaluating device, and effectiveness evaluating program for external preparation for skin
09/30/2010US20100247442 Macaca fascicularis ST2L
09/30/2010US20100247441 Site localization and methods for monitoring treatment of disturbed blood vessels
09/30/2010US20100247440 Mycobacterial immunotherapy for cancer treatment
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010US20100247438 In vitro method for diagnosing tumor diseases
09/30/2010US20100247437 Materials and methods for the delivery of biomolecules to cells of an organ
09/30/2010US20100247436 In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles
09/30/2010US20100247435 Measurement of neural activity
09/30/2010US20100247433 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
09/30/2010CA2756634A1 Site localization and methods for monitoring treatment of disturbed blood vessels
09/30/2010CA2756181A1 Carrier
09/29/2010EP2231765A2 Polysaccharide nanoparticles
09/29/2010EP2231659A1 Translocator protein ligands
09/29/2010EP2231200A1 Contrast agents
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 354